A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbuilt Cancer Center Affiliate Network (VCCAN) Trial
- 1 April 2000
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 1, S27-S31
- https://doi.org/10.3816/clc.2000.s.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A phase II trial of docetaxel in advanced nonsmall cell lung cancerAnti-Cancer Drugs, 1996
- Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) culturesAnti-Cancer Drugs, 1996
- Docetaxel in stage III and IV non-small cell lung cancerEuropean Journal Of Cancer, 1995
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- Investigation of taxol as a potential radiation sensitizerCancer, 1993
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Unresectable squamous cell carcinoma of the lung and its management by combined bleomycin and radiotherapy.A clinical study of the enhanced resultsCancer, 1976